Search research articles
Contact Us
Filters
Showing results (521-530 of 645) with videos related to
Page
of 65
Sort By:
Cancer Genetics
|
July 4, 2012
Detection of TET2 abnormalities by fluorescence in situ hybridization in 41 patients with myelodysplastic syndrome
Irene Dambruoso, Marina Boni, Marianna Rossi, et al.
British Journal of Haematology
|
June 13, 2002
Natural history of juvenile haemochromatosis
Marco De Gobbi, Antonella Roetto, Alberto Piperno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2007
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes
Luca Malcovati, Ulrich Germing, Andrea Kuendgen, et al.
Blood
|
April 12, 2007
Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation
Francesco Passamonti, Maria Luigia Randi, Elisa Rumi, et al.
British Journal of Haematology
|
October 6, 2007
Gene expression profiling of CD34+ cells in patients with the 5q- syndrome
Jacqueline Boultwood, Andrea Pellagatti, Helen Cattan, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 26, 2023
An Update on Outcomes for COPD Pharmacological Trials: A COPD Investigators Report - Reassessment of the 2008 American Thoracic Society/European Respiratory Society Statement on Outcomes for COPD Pharmacological Trials
Mario Cazzola, Paola Rogliani, Peter J Barnes, et al.
Blood Cancer Journal
|
December 9, 2017
CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles
Roberta Zini, Paola Guglielmelli, Daniela Pietra, et al.
Blood
|
February 26, 2004
Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis
Carmela Lanzara, Antonella Roetto, Filomena Daraio, et al.
Blood
|
March 19, 2015
Impact of allogeneic stem cell transplantation on survival of patients less than 65 years of age with primary myelofibrosis
Nicolaus Kröger, Toni Giorgino, Bart L Scott, et al.
Blood
|
July 4, 2013
NOTCH1, SF3B1, and TP53 mutations in fludarabine-refractory CLL patients treated with alemtuzumab: results from the CLL2H trial of the GCLLSG
Andrea Schnaiter, Peter Paschka, Marianna Rossi, et al.
Page
of 65
Search research articles
Search
Showing results (521-530 of 645) with videos related to
Sort By:
Page
of 65
Cancer Genetics
|
July 4, 2012
Detection of TET2 abnormalities by fluorescence in situ hybridization in 41 patients with myelodysplastic syndrome
Irene Dambruoso, Marina Boni, Marianna Rossi, et al.
British Journal of Haematology
|
June 13, 2002
Natural history of juvenile haemochromatosis
Marco De Gobbi, Antonella Roetto, Alberto Piperno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2007
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes
Luca Malcovati, Ulrich Germing, Andrea Kuendgen, et al.
Blood
|
April 12, 2007
Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation
Francesco Passamonti, Maria Luigia Randi, Elisa Rumi, et al.
British Journal of Haematology
|
October 6, 2007
Gene expression profiling of CD34+ cells in patients with the 5q- syndrome
Jacqueline Boultwood, Andrea Pellagatti, Helen Cattan, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 26, 2023
An Update on Outcomes for COPD Pharmacological Trials: A COPD Investigators Report - Reassessment of the 2008 American Thoracic Society/European Respiratory Society Statement on Outcomes for COPD Pharmacological Trials
Mario Cazzola, Paola Rogliani, Peter J Barnes, et al.
Blood Cancer Journal
|
December 9, 2017
CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles
Roberta Zini, Paola Guglielmelli, Daniela Pietra, et al.
Blood
|
February 26, 2004
Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis
Carmela Lanzara, Antonella Roetto, Filomena Daraio, et al.
Blood
|
March 19, 2015
Impact of allogeneic stem cell transplantation on survival of patients less than 65 years of age with primary myelofibrosis
Nicolaus Kröger, Toni Giorgino, Bart L Scott, et al.
Blood
|
July 4, 2013
NOTCH1, SF3B1, and TP53 mutations in fludarabine-refractory CLL patients treated with alemtuzumab: results from the CLL2H trial of the GCLLSG
Andrea Schnaiter, Peter Paschka, Marianna Rossi, et al.
Page
of 65